As of November 7, 2024, Electromed, Inc. reported having 8,458,005 shares of common stock outstanding. For the three months ending September 30, 2024, the company achieved net revenues of $14,668,000, marking a 19.0% increase from $12,324,000 during the same period in 2023. This growth was primarily driven by an increase in homecare revenue, which rose by $2,058,000 (18.5%) to $13,211,000. Additionally, hospital revenue experienced a significant increase of $183,000 (36.1%), reaching $690,000.

The gross profit for the quarter was $11,491,000, which accounted for 78.3% of net revenues, an improvement from $9,498,000 (77.1%) in the prior year. Operating income saw a substantial rise to $1,938,000 for the three months ended September 30, 2024, compared to just $142,000 in the same period of 2023. This increase in profitability is reflected in the net income, which surged to $1,474,000, a notable increase from $155,000 in the previous year.

Cash flows from operating activities for the quarter were reported at $2,309,000, driven by net income and changes in working capital. As of September 30, 2024, Electromed, Inc. had total assets amounting to $48,915,000 and total shareholders' equity of $41,488,000. The company also maintained a credit facility with a $2,500,000 revolving line of credit, with no outstanding balance as of the reporting date.